Head and Neck Neoplasms
📧 Sign up to get email alerts when something new happens for Head and Neck Neoplasms.
Sign up freeTop drugs studied for this disease
-
EMA approval · 2026-08-06EMA Authorised: Docetaxel Kabi (docetaxel) — Fresenius Kabi Deutschland GmbH
EU authorization of Docetaxel Kabi (docetaxel) for multiple cancer indications including head and neck neoplasms, non-small cell lung carcin…
-
EMA approval · 2026-07-15EMA Authorised: Erbitux (cetuximab) — Merck Europe B.V.
Erbitux (cetuximab) has been authorised by EMA for therapeutic areas including head and neck neoplasms and colorectal neoplasms.